Introduction
Cholesteryl ester transfer protein (CETP) and apolipoprotein E (apoE) are two important proteins involved in lipid metabolism and known to affect the plasma lipid concentration [1] . ApoE is the major apolipoprotein constituent of triglyceride-rich very low density lipoproteins (VLDL), low density lipoproteins (LDL) and chylomicron remnant particles and serves as a high affinity ligand of the hepatic LDL receptor and LDL receptor-related protein-1 (LRP-1), important for lipoprotein catabolism in the liver. ApoE is encoded by a polymorphic gene (APOE) located on chromosome 19 and which has three common alleles: ε2, ε3, ε4. These three alleles are translated into 3 isoforms of apoE (E2, E3, E4) by the substitution of Arginine and Cysteine at positions 112 (rs429358) and/or 158 (rs7412) in the protein, determining the apparition of six different APOE genotypes [2] . Data from literature identify APOE genotype as a strong genetic risk factor for various ageing-related diseases, including dementia. Carriers of ε4 allele have an increased risk of developing cognitive disabilities [3, 4] , whereas ε2 allele carriers are relatively protected [5, 6] .
CETP is a hydrophobic glycoprotein which transfers cholesterol esters from the high density lipoproteins (HDL) to triglycerides-rich particles (such as VLDL) in exchange for the triglycerides from the latter [7] . The gene coding for CETP encompasses 16 exons and is localized on chromosome 16q21. It has been demonstrated that the CETP gene is polymorphic, one of the most widely studied polymorphisms being TaqIB (rs708272), which results from a silent mutation in nucleotide 277, in intron 1 of the gene [8] . The mutation determines the presence or absence of a TaqIB restriction site, which leads to three possible genotypes associated with B1 and B2 alleles. Published data demonstrate that the B2 allele is associated with lower CETP levels as compared to the B1 allele, and that the CETP TaqIB genotype is strongly associated with the risk of cardiovascular diseases (CVD), carriers of B2B2 genotypes having higher levels of HDL cholesterol and a lower risk of CVD [9] . Recently, Murphy et al. showed that CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOEdependent manner [10] , raising the importance to study the variations of the two genes in a interaction approach.
The aim of our study was to determine the association between APOE and CETP TaqIB gene polymorphisms with healthy ageing in a Romanian population. We considered healthy ageing the process in which subjects do not have CVD and cognitive impairment.
Experimental Procedures

Subjects
The study included 317 subjects of both genders, divided by age into two groups: (1) 267 elderly subjects aged 55-80+ years and (2) 50 control subjects between 35-55 years, selected from a Romanian population. The elderly subjects were also divided by mini mental state examination score (MMSE) into (i) 163 elderly subjects with mild cognitive impairment (MMSE<28), and (ii) 104 elderly healthy subjects without cognitive impairment (MMSE≥28). The MMSE (or Folstein) test is a brief 30-point questionnaire test that was used to screen for cognitive impairment [11] . From these subjects, 211 were women (72.3%) and 81 men (27.7%), with the same gender distribution in each group. From each subject, fasting blood samples were taken on ethylene-diamine-tetra-acetic acid for biochemical and hormonal analysis and DNA isolation from circulating leukocytes was done. The body mass index (BMI), waist circumference, systolic and diastolic blood pressure (BP) were recorded for each subject. All participants gave written informed consent.
Plasma assays
Plasma cholesterol, HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), total apoB, apoA-I, glucose, triglycerides, collagen, C-reactive protein (CRP), thyroid hormones (free T3, T3, T4 and thyroid stimulating hormone (TSH)) levels were assayed using commercial kits, within the current analysis with automated biochemical or immuno-turbidimetric analyzers in the Hospital laboratory.
DNA genotyping
APOE (rs429358 and rs7412) and CETP TaqIB (rs708272) gene polymorphisms were determined by PCR-restriction fragment length polymorphism (RFLP) method, by using genomic DNA isolated from peripheral leukocytes.
APOE genotyping. A fragment of 244 bp in exon 4 of the APOE gene was amplified by PCR using specific primers, as previously described [12] . CETP genotyping. A fragment of 1420-bp was amplified by PCR using specific primers, as previously described [13] . The PCR products were digested with 10 U/μl reaction TaqIB restriction enzyme (Promega GmbH, Mannheim, Germany) and the digestion product was run on a 2% agarose gel. The CETP B1B1 genotype was identified as two bands of 750 bp and 670 bp, the B1B2 genotype as 750 bp, 670 bp and 1420 bp, and the B2B2 genotype as the starting undigested 1420 bp on the agarose gels.
All the PCR reactions were performed in a Thermo PX2 thermal cycler (Thermo Fisher Scientific, Waltham, MA, USA). The resulting enzyme-digested fragments of the PCR products fractionated on 16% polyacrylamide or 2% agarose gels were stained with ethidium bromide and visualized under UV light with an ImageMaster imaging system (Amersham-Pharmacia Biosciences, Piscataway, NJ, USA).
Statistical analysis
Statistical analysis was performed using the SPSS 15.0 software for Windows (SPSS Inc., Chicago, IL, USA). Allele and genotype frequencies were determined by direct counting. The normal quantitative variables (anthropometric, biochemical and hormonal data) were expressed as means ± standard deviation (SD) and were analysed by using two-sample T-test or ANOVA test. For some statistical analysis, heterozygous and homozygous genotype carriers were pooled to obtain a better significance (i.e. biochemical parameters in aged subjects with cognitive impairment B1B1 as compared to B1B2+B2B2). Significant differences of continuous variables were assessed by using two tests, the Student's T-test, analysis of variance (One-way ANOVA) (biochemical, hormonal and anthropological parameters), and for categorical ones we used χ-square test, and Mantel-Haenszel common odds ratios (OR) estimates (alleles and genotypes frequencies, combined genotypes analysis). The threshold for statistical significance was set to 5% (P-values lower than 0.05).
Results
Plasma parameters of the subjects
Biochemical, endocrine and anthropometric mean values of the parameters of elderly and control subjects are presented in Table 1 . The elderly subjects had statistically significant increased plasma HDL-C and circulating collagen, and decreased waist circumference and thyroid hormone T3 levels, as compared to control subjects.
The elderly subjects with cognitive impairment presented statistically significant increased systolic BP and plasma collagen levels compared to the elderly healthy subjects. The levels of HDL-C, apolipoprotein A-I main HDL protein, TSH, T3 and T4 hormones in the plasma of elderly subjects with cognitive impairment were decreased as compared to the elderly healthy subjects (Table 2) .
Distribution of APOE alleles and genotypes in elderly and control subjects
The APOE genotypes did not deviate from HardyWeinberg equilibrium in the entire group, in control, as well as in elderly subjects group. Analysis of the APOE gene polymorphisms in all the studied subjects revealed the following general distribution: 
Association of APOE alleles and genotypes with biochemical parameters in elderly and control subjects
Elderly carriers of the ε2 allele had increased plasma levels of triglycerides (P=0.041) as compared with 
Distribution of APOE alleles and genotypes in elderly subjects with cognitive impairment
The distribution of APOE alleles and genotypes did not differ between the elderly subjects with cognitive impairment and the elderly healthy subjects ( Figure 1 and Table 5 -Supplementary Material). However, APOE 3/2 genotype frequency was higher in the elderly healthy subjects (20.4%), while in the group of elderly subjects with cognitive impairment it was only 12.8%; the difference was not statistically significant (χ 2 -test P-value NS (not significant), OR=1.651, 95% CI 0.834-3.265, P-value NS). No association between APOE alleles or genotypes with pathological values of biochemical parameters, CRP and thyroid hormones levels was observed in the elderly subjects with cognitive impairment.
Distribution of CETP alleles and genotypes in elderly and control subjects
The CETP genotypes did not deviate from HardyWeinberg equilibrium in the entire group, in controls, as well as in elderly subjects group. The overall distribution of CETP TaqIB alleles in the studied group was: 60.6% for B1 and 39.4% for B2, while the genotype distribution was: 36.3% for B1B1, 48.5% for B1B2, and 15.2% for B2B2. No statistical differences in the distribution of CETP alleles and genotypes were observed for the elderly subjects as compared to controls ( Figure 2 and Table 3 ).
Association of CETP genotypes with biochemical parameters in elderly and control subjects
The CETP B1B2 and B2B2 genotypes were correlated with lower waist circumference (P=0.002), lower levels of LDL-C (P=0.028) and apoB (P=0.050) in elderly subjects compared to controls. There was no association between the other biochemical parameters, CRP and thyroid hormones levels with CETP genotype distribution in elderly and control groups (data not shown). Figure 2 . Distribution of CETP genotypes in elderly and control subjects (A), and in elderly subjects with and without cognitive impairment (B).
Distribution of CETP alleles and genotypes in elderly subjects with cognitive impairment
The distribution of CETP genotypes differed between the elderly subjects with and without cognitive impairment (P=0.026) (Figure 2) . CETP B2 allele was present in 58.4% of elderly subjects with cognitive impairment, while in elderly healthy subjects B2 allele frequency was 73.6%, a statistically significant difference (P=0.017), which suggests an association of B2 allele with healthy ageing (Table 3) . Interestingly, an increased frequency of the B1B1 genotype in elderly subjects with cognitive impairment (41.6%) was also observed, as compared to age-matched subjects without cognitive impairment (26.4%, P=0.019) (Figure 2 ).
Association of CETP genotypes with biochemical parameters in elderly subjects with cognitive impairment
The CETP B1B2 genotype in elderly subjects with cognitive impairment was associated with lower plasma apoA-I (P=0.021) and higher collagen type I (P=0.001) levels, as compared to the elderly healthy subjects ( Figures 3A, B) . Moreover, the B1B1 genotype was associated with higher systolic BP in elderly subjects with cognitive impairment, as compared to the elderly healthy subjects ( Figure 3C ). There was no difference between CETP genotypes distribution and hormonal status in elderly subjects with and without cognitive impairment. CETP activity measured in plasma isolated from all subjects did not differ between the elderly and control groups, as well as between elderly subjects with and without cognitive impairment (data not shown).
Combined genotypes of APOE and CETP in cognitive impairment
In order to evaluate the association between the APOE and CETP gene polymorphisms, we analysed the distribution of the six possible combined genotypes defined by the APOE ε3/ε4/ε2 and CETP B1/B2 alleles for the studied subjects. We found that there was no association between APOE ε4 distribution and CETP B1 distribution within any of the studied groups (Table 4) . Moreover, we observed an interesting association of the APOE ε2 allele distribution with the CETP B2 allele in elderly subjects: healthy elderly subjects had an increased frequency of the APOE ε2/ CETP B2 combined genotype (18.3%) as compared to the mentally affected elderly subjects (7.6%, P=0.011) ( Table 4 ). There was no statistically significant with other reports showing that the APOE ε4 allele is not associated with cognitive deficit [19] [20] [21] . Other investigators, however, reported that the presence of at least one ε4 allele was associated with faster cognitive decline in Alzheimer's disease patients [22] . The presence of the ε4 allele was also recently associated with impaired memory function in both middle-aged and older subjects with mild cognitive impairment [23] . A recent genome-wide association study confirms APOE as one of the major gene influencing survival in long-lived individuals [24] . This study independently confirmed the APOE-longevity association, thus strengthening the conclusion that this locus is a very, if not the most, important genetic factor influencing longevity. We observed no association of the ε2 allele or ε2-containing genotypes with ageing or with cognitive impairment, either in men or women. However, we found that the elderly carriers of the ε2 allele had increased levels of triglycerides relative to control subjects. In contrast, Martins et al. demonstrated that APOE genotype strongly predicts the rate of cognitive decline in Alzheimer's disease, a dose-response relation existing with the APOE ε4 allele, while the APOE ε2 allele was protective [25] .
We investigated a possible association between APOE alleles, thyroid hormone levels and cognitive difference for the distribution of the other two combined genotypes (APOE ε3/CETP B2 and APOE ε4/CETP B2) (data not shown). However, no association was found for any of these combined genotypes with biochemical and metabolic parameters, CRP and thyroid hormones levels in the studied subjects.
Discussion
In the present study we evaluated the association of APOE and CETP TaqIB gene polymorphisms with successful ageing in a selected group of Romanian subjects by analysing their cognitive status and biochemical and hormonal parameters. We observed that both distributions of APOE and CETP TaqIB alleles and genotypes in the studied groups were similar to the one reported for other EuropeanCaucasian populations [14, 15] . Polymorphism of the APOE gene was proposed as an important risk factor for Alzheimer's disease and other neurological disabilities associated with ageing [16] [17] [18] .
Data from the present study show no association between the frequency of the ε4 allele and biochemical or hormonal parameters in elderly carriers relative to control subjects. Our results are in good agreement impairment. Our results show no statistical association between APOE polymorphisms and any of the above parameters in the elderly subjects. However, we demonstrate that elderly subjects with cognitive impairment have lower T3, T4 and TSH hormone levels, and higher systolic BP, compared to elderly healthy subjects. This result was in agreement with van Osch et al., who reported that Alzheimer's disease patients had significantly lower levels of TSH [26] . Lower levels of TSH were associated with a more than two-fold increased risk of Alzheimer's disease, independently of other risk factors.
Although APOE gene polymorphism is associated with variable risks for several diseases, no clear relationship has been demonstrated with vascular frailty. We report here that none of the APOE alleles or genotypes were associated with decreased levels of type I collagen, an accepted index of frailty, in elderly subjects relative to controls, in a good agreement with the results of Rockwood et al. [27] .
Our data show that the analysed CETP TaqIB alleles and associated genotypes have the same distribution in both elderly and control subjects, in good agreement with Ordovas et al. [9] . The CETP B2 allele is associated with lower LDL-cholesterol and total apoB levels in elderly subjects relative to young controls. We observed an association of the B2 allele with diminished obesity in elderly subjects, indicated by a lower waist circumference as compared to controls, while similar data were reported by Brousseau et al. [28] .
Our observations show that CETP activity measured in plasma isolated from all subjects did not differ between the elderly and control groups, as well as between elderly subjects with and without cognitive impairment (data not shown). Arai et al. observed that although heterozygosity for the CETP B2 allele was consistently associated with higher HDL-cholesterol levels both in centenarians and controls, the distribution of CETP TaqIB alleles did not differ between the two groups [13] .
To the best of our knowledge, there are no published data on the role of CETP TaqIB polymorphism in ageing and ageing-related cognitive impairment. Our results show that the distribution of CETP TaqIB genotypes is similar in elderly subjects, either with or without cognitive impairment. However, we found an increased frequency of the B1B1 genotype in elderly subjects with cognitive impairment as compared to healthy elderly subjects, and this result might be of particular interest. Moreover, the CETP B2 allele has a lower frequency in elderly subjects with cognitive impairment. We also observed the association of the B1 allele with decreased plasma apoA-I concentrations and increased collagen levels, while the B1 allele was associated with increased systolic BP in cognitively-impaired elderly subjects. Our results suggest that the CETP B2 allele may be protective against cerebrovascular diseases.
The data reported here support the importance of the distribution of combined APOE and CETP genotypes in elderly subjects. We demonstrate an interesting association of the APOE ε2 allele and the CETP B2 allele with healthy ageing. Our results confirm and expand Muendlein et al. previous report on the synergistic effect of APOE ε3/ε2/ε4, CETP TaqIB and APOC3 -482C>T polymorphisms in Caucasian patients with CVD [29] .
In summary, we propose that the CETP B2 allele may play a protective role in successful ageing and longevity that could be enhanced by the co-existence of APOE ε2 allele. Our results suggest that the population analysis of genetic risk factors for cognitive impairment in ageing should consider the possible contribution of these combined genotypes.
